NM_001386140.1:c.294G>C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001386140.1(MTTP):​c.294G>C​(p.Glu98Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0509 in 1,613,268 control chromosomes in the GnomAD database, including 3,733 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.086 ( 1009 hom., cov: 32)
Exomes 𝑓: 0.047 ( 2724 hom. )

Consequence

MTTP
NM_001386140.1 missense

Scores

2
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.225

Publications

32 publications found
Variant links:
Genes affected
MTTP (HGNC:7467): (microsomal triglyceride transfer protein) MTP encodes the large subunit of the heterodimeric microsomal triglyceride transfer protein. Protein disulfide isomerase (PDI) completes the heterodimeric microsomal triglyceride transfer protein, which has been shown to play a central role in lipoprotein assembly. Mutations in MTP can cause abetalipoproteinemia. [provided by RefSeq, Jul 2008]
MTTP Gene-Disease associations (from GenCC):
  • abetalipoproteinemia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics, PanelApp Australia, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.001547575).
BP6
Variant 4-99583418-G-C is Benign according to our data. Variant chr4-99583418-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 347021.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr4-99583418-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 347021.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr4-99583418-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 347021.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr4-99583418-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 347021.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr4-99583418-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 347021.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr4-99583418-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 347021.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr4-99583418-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 347021.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr4-99583418-G-C is described in CliVar as Benign/Likely_benign. Clinvar id is 347021.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.188 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MTTPNM_001386140.1 linkc.294G>C p.Glu98Asp missense_variant Exon 3 of 18 ENST00000265517.10 NP_001373069.1
MTTPNM_000253.4 linkc.294G>C p.Glu98Asp missense_variant Exon 4 of 19 NP_000244.2 P55157-1
MTTPNM_001300785.2 linkc.45G>C p.Glu15Asp missense_variant Exon 3 of 18 NP_001287714.2 P55157B7Z7X3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MTTPENST00000265517.10 linkc.294G>C p.Glu98Asp missense_variant Exon 3 of 18 1 NM_001386140.1 ENSP00000265517.5 P55157-1

Frequencies

GnomAD3 genomes
AF:
0.0856
AC:
13003
AN:
151976
Hom.:
1005
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.192
Gnomad AMI
AF:
0.0362
Gnomad AMR
AF:
0.0641
Gnomad ASJ
AF:
0.0493
Gnomad EAS
AF:
0.188
Gnomad SAS
AF:
0.0472
Gnomad FIN
AF:
0.0169
Gnomad MID
AF:
0.0510
Gnomad NFE
AF:
0.0345
Gnomad OTH
AF:
0.0670
GnomAD2 exomes
AF:
0.0592
AC:
14750
AN:
249084
AF XY:
0.0546
show subpopulations
Gnomad AFR exome
AF:
0.194
Gnomad AMR exome
AF:
0.0542
Gnomad ASJ exome
AF:
0.0499
Gnomad EAS exome
AF:
0.190
Gnomad FIN exome
AF:
0.0210
Gnomad NFE exome
AF:
0.0343
Gnomad OTH exome
AF:
0.0442
GnomAD4 exome
AF:
0.0473
AC:
69149
AN:
1461174
Hom.:
2724
Cov.:
32
AF XY:
0.0466
AC XY:
33854
AN XY:
726872
show subpopulations
African (AFR)
AF:
0.197
AC:
6591
AN:
33444
American (AMR)
AF:
0.0533
AC:
2384
AN:
44700
Ashkenazi Jewish (ASJ)
AF:
0.0501
AC:
1309
AN:
26102
East Asian (EAS)
AF:
0.212
AC:
8408
AN:
39654
South Asian (SAS)
AF:
0.0408
AC:
3520
AN:
86212
European-Finnish (FIN)
AF:
0.0207
AC:
1099
AN:
53218
Middle Eastern (MID)
AF:
0.0609
AC:
351
AN:
5760
European-Non Finnish (NFE)
AF:
0.0378
AC:
42034
AN:
1111706
Other (OTH)
AF:
0.0572
AC:
3453
AN:
60378
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
3410
6819
10229
13638
17048
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1826
3652
5478
7304
9130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0856
AC:
13024
AN:
152094
Hom.:
1009
Cov.:
32
AF XY:
0.0837
AC XY:
6220
AN XY:
74356
show subpopulations
African (AFR)
AF:
0.192
AC:
7957
AN:
41490
American (AMR)
AF:
0.0639
AC:
975
AN:
15256
Ashkenazi Jewish (ASJ)
AF:
0.0493
AC:
171
AN:
3470
East Asian (EAS)
AF:
0.187
AC:
970
AN:
5174
South Asian (SAS)
AF:
0.0468
AC:
226
AN:
4826
European-Finnish (FIN)
AF:
0.0169
AC:
179
AN:
10604
Middle Eastern (MID)
AF:
0.0479
AC:
14
AN:
292
European-Non Finnish (NFE)
AF:
0.0345
AC:
2347
AN:
67958
Other (OTH)
AF:
0.0720
AC:
152
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
547
1094
1640
2187
2734
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
136
272
408
544
680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0458
Hom.:
202
Bravo
AF:
0.0937
TwinsUK
AF:
0.0426
AC:
158
ALSPAC
AF:
0.0374
AC:
144
ESP6500AA
AF:
0.186
AC:
818
ESP6500EA
AF:
0.0408
AC:
351
ExAC
AF:
0.0604
AC:
7329
Asia WGS
AF:
0.109
AC:
376
AN:
3478
EpiCase
AF:
0.0362
EpiControl
AF:
0.0337

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Dec 13, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 28008009) -

Abetalipoproteinaemia Benign:2
Nov 21, 2019
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not specified Benign:1
Sep 19, 2019
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.093
BayesDel_addAF
Benign
-0.65
T
BayesDel_noAF
Benign
-0.56
CADD
Benign
13
DANN
Uncertain
0.98
DEOGEN2
Benign
0.017
T;.;T;T;.
Eigen
Benign
-0.43
Eigen_PC
Benign
-0.31
FATHMM_MKL
Benign
0.57
D
LIST_S2
Benign
0.55
T;T;.;T;T
MetaRNN
Benign
0.0015
T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Uncertain
2.3
.;.;M;M;M
PhyloP100
0.23
PrimateAI
Benign
0.29
T
PROVEAN
Benign
-0.86
N;N;N;N;N
REVEL
Benign
0.026
Sift
Benign
0.12
T;T;T;T;T
Sift4G
Benign
0.40
T;T;T;T;T
Polyphen
0.20, 0.71
.;B;P;P;.
Vest4
0.049, 0.046, 0.044
MutPred
0.28
.;Gain of glycosylation at S127 (P = 0.0253);.;.;.;
MPC
0.22
ClinPred
0.0048
T
GERP RS
2.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.050
gMVP
0.29
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2306986; hg19: chr4-100504575; COSMIC: COSV55503825; COSMIC: COSV55503825; API